Advancements In Tumor Microenvironment-Responsive Intelligent Nanomedicine Delivery Systems for Breast Cancer Treatment

Shengzhe Zhuang

doi:10.54097/dvc2g030

Authors

Shengzhe Zhuang

DOI:

https://doi.org/10.54097/dvc2g030

Keywords:

Tumor microenvironment; intelligent nanomedicine delivery system; breast cancer treatment.

Abstract

Breast cancer severely threatens women's health. Traditional therapeutic approaches face numerous limitations, including an inability to overcome significant physiological and pathological barriers, as well as notable toxic side effects. Tumor microenvironment-responsive intelligent nanomedicine delivery systems leverage the characteristics of the tumor microenvironment to deliver drugs, offering new hope for breast cancer treatment. This article comprehensively reviews the research progress of these systems in breast cancer therapy, including the characteristics of the tumor microenvironment, design principles of various responsive nanomedicine delivery systems, application examples, and future directions for development.

Downloads

Download data is not yet available.

References

[1] Pallavi Velapure，Divyanshi kansal，Chandrashekhar Bobade. Tumor microenvironment–responsive nanoformulations for breast cancer. Nanoscale Research Letters. Vol. 19 (2024) No. 1, p. 212.

[2] Weigelt B, Geyer FC, Reis-Filho JS. Histological types of breast cancer: how special are they? Molecular Oncology. Vol. 4 (2010) No. 3, p. 192-208.

[3] Trayes KP, Cokenakes SEH. Breast Cancer Treatment. Am Fam Physician. Vol. 104 (2021) No. 2, p. 171-178

[4] Zheng RS, Chen R, Han BF, et al. Cancer incidence and mortality in China, 2022. Zhonghua Zhong Liu Za Zhi. Vol. 46 (2024) No. 3, p. 221-231.

[5] Zhang Z, Liu LF, Liu YT, et al. Interpretation of global cancer statistics report 2022. Chinese journal of hospital statistics. Vol. 31 (2024) No. 5, p. 393-400.

[6] Lei S, Zheng R, Zhang S, et al. Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030. Cancer Biol Med. Vol. 18 (2021) No. 3, p. 900-909

[7] Bissell MJ, Radisky DC, Weaver VM, et al. The organizing principle:microenvironmental influences in the normal and malignant breast. Differentiation. Vol. 70 (2002) No. 9-10, p. 537-46.

[8] Boudreau A, Van't-veer U, Bissell MJ. An "elite hacker": breast tumors exploit the normal,microenvironment program to instruct their progression and biological diversity. Vol. 6 (2012) No. 3, p. 236-248.

[9] Weaver VM, Fischer AH, Peterson OW, et.al. The importandce of the microenvironment,in breast cancer progression: recapitulation of mammary tumorigenesis using a unique human,mammary epithelial cell model and a three-dimensional culture assay.Biochem.Cell.Biol. Vol. 74 (1996) No. 6, p. 833-851.

[10] Lochter A, Bissell MJ. Involvement of extracellular matrix constituents in breast cancer.Semin Cancer Biol.Jun. Vol. 6 (1995) No. 3, p. 165-173.

[11] Davis ME, Chen ZG, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov. Vol. 7 (2008) No. 9, p. 771-782.

[12] Torchilin VP. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nat Rev Drug Discov. Vol. 13 (2014) No. 11, p. 813-827.

[13] Rojas K, Spring LM, O'Riordan L, et al. Endocrine Therapy for Surgeons: Practical Pearls for Managing Menopausal, Bone Loss and Sexual Adverse Effects. Ann Surg Oncol. Vol. 30 (2023) No. 10, p. 5951-5961.

[14] Ahmed TA, Aljaeid BM. Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery. Drug Des Devel Ther. Vol. 10 (2016) p. 483-507.

[15] Guo F, Guo D, Zhang W, et al. Preparation of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles by a microchannel technology. Vol. 99 (2017) p. 328-336.

[16] Zuo T, Li J, Zhang J, et al. Coadministration of chemotherapy and PI3K/Akt pathway treatment with multistage acidity/CathB enzyme-responsive nanocarriers for inhibiting the metastasis of breast cancer. Biomater Sci. Vol. 7 (2019) No. 12, p. 5054-5067.

[17] Sun T, Li J, Liu R, et al. TAT-modifiedredox-sensitive nanoparticles for triggered drug delivery and effective breast cancer therapy. Drug Delivery Sci. Vol. 57 (2020) p. 813-827.

[18] Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. Vol. 21 (2012) No. 3, p. 309-322.

[19] N. Illy, V. Corce, J. Zimbron, et al. pH - sensitive poly (ethylene glycol)/poly (ethoxyethyl glycidyl ether) block copolymers: synthesis, characterization, encapsulation, and delivery of a hydrophobic drug Macromol. Chem. Vol. 220 (2019) No. 16, 1900210.

[20] Liu HH, Shi XF, Wang QN, et al. Preparation of pH responsive magnetic mesoporous nano drug delivery system. Chemical Industry and Engineering Progress. Vol. 42 (2023) No. 10, p. 5390-5398.

[21] Shen Y, Zhang J, Hao W, et al. Copolymer micelles function as pH-responsive nanocarriers to enhance the cytotoxicity of a HER2 aptamer in HER2-positive breast cancer cells. Int J Nanomedicine. Vol. 13 (2018) p. 537-553.

[22] Li Z, Song N, Yang Y. Stimuli-Responsive Drug-Delivery Systems Based on Supramolecular Nanovalves. Matter. Vol. 1 (2019) No. 2, p. 345-368.

[23] Xie M, Meng F, Wang P, et al. Surface Engineering of Magnetic Iron Oxide Nanoparticles for Breast Cancer Diagnostics and Drug Delivery. Int J Nanomedicine. Vol. 19 (2024) p. 8437-8461

[24] Sang M, Luo R, Bai Y, et al. Mitochondrial membrane anchored photosensitive nano-device for lipid hydroperoxides burst and inducingferroptosis to surmount therapy-resistant cancer. Theranostics. Vol. 9 (2019) No. 21, p. 6209-6223.

[25] Chen Y, Li X, Luo K, et al. Hyperthermia/glutathione-triggered ferritin nanoparticles amplify the ferroptosis for synergistic tumor therapy. Mater Today Bio. Vol. 26 (2024) 101085.

[26] Wu M, Zhang X, Zhang W, et al. Cancer Stem Cell Regulated Phenotypic Plasticity Protects Metastasized Cancer Cells from Ferroptosis. NatCommun. Vol. 13 (2022) No. 1, 1371.

[27] Ahmed S, Khan H, Fratantonio D, et al. Apoptosis induced by luteolin in breast cancer: Mechanistic and therapeutic perspectives. Phytomedicine Vol. 59 (2019) 152883.

[28] Wang Y, Wang Q, Feng W, et al. Folic acid-modified ROS-responsive nanoparticles encapsulating luteolin for targeted breast cancer treatment. Drug Delivery. Vol. 28 (2021) No. 1, p. 1695-1708.

[29] R.E. Vandenbroucke, S.C. De Smedt, J. Demeester, et al. Cellular entry pathway and gene transfer capacity of TAT-modified lipoplexes. Biochim Biophys Acta. Vol. 1768 (2007) No. 3, p. 571-579.

[30] X.B. Xiong, H. Uludağ, A. Lavasanifar. Virus-mimetic polymeric micelles for tar-geted siRNA delivery. Biomaterials. Vol. 31 (2010) No. 22, p. 5886-5893.

[31] L. Pan, J. Liu, Q. He, et al. Overcoming multidrug resistance of cancer cells by direct intranuclear drug delivery using TAT-conjugated mesoporous silica nanoparticles. Biomaterials. Vol. 34 (2013) No. 11, p. 2719-2730.

[32] V.P. Torchilin. Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers. Adv Drug Deliv Rev. Vol. 60 (2008) No. 4-5, p. 548-558.

[33] Sameiyan E, Bagheri E, Dehghani S, et al. Aptamer-based ATP-responsive delivery systems for cancer diagnosis and treatment. Acta Biomater. Vol. 123 (2021) p. 110-122.

[34] R. Mo, T. Jiang, R. DiSanto, et al. ATP-triggered anticancer drug delivery. Nat Commun. Vol. 5 (2014) p. 1-10.

[35] L.R. MacGillivray. Metal-Organic Frameworks: Design and Application. John Wiley & Sons, 2010 .

[36] D. Farrusseng. Metal-organic frameworks: Applications from catalysis to gas storage. John Wiley & Sons, 2011 p. 392.

[37] A.U. Czaja, N. Trukhan, U. Müller. Industrial applications of metal–organic frameworks. Chem Soc Rev. Vol. 38 (2009) No. 5, p. 1284-1293.

[38] Chen WH, Yu X, Liao WC, et al. ATP-responsive aptamer-based metal–organic framework nanopar-ticles (NMOFs) for the controlled release of loads and drugs. Advanced Functional Materials. Vol. 27 (2017) No. 37, 1702102.

[39] Guo F, Du Y, Wang Y, et al. Targeted drug delivery systems for matrix metalloproteinase-responsive anoparticles in tumor cells: A review. Int J Biol Macromol. Vol. 257 (2024) 128658.

[40] Xiao Q, Zhu X, Yuan Y, et al. A drug-delivering-drug strategy for combined treatment of metastatic breast cancer. Nanomedicine. Vol. 14 (2018) No. 8, p. 2678-2688.

[41] Liu Y, Tang R, Cao Y, et al. LIFU/MMP-2 dual-responsive release of repurposed drug disulfiram from nanodroplets for inhibiting vasculogenic mimicry and lung metastasis in triple-negative breast cancer. J Nanobiotechnology. Vol. 22 (2024) No. 1, p. 209.

[42] Li QL, Xu SH, Zhou H, et al. pH and Glutathione Dual-Responsive Dynamic Cross-Linked Supramolecular Network on Mesoporous Silica Nanoparticles for Controlled Anticancer Drug Release. ACS Appl Mater Interfaces. Vol. 7 (2015) No. 51, p. 28656-28664.

[43] Na Re, K., Young, S., Van, Hong, et al. Dual pH- and GSH-responsive degradable PEGylated graphene quantum dot-based nanoparticles for enhanced HER2-positive breast cancer therapy. Nanomaterials. Vol. 10 (2020) No. 1, p. 91.

[44] Boutilier AJ, Elsawa SF. Macrophage polarization states in the tumor microenvironment. International Journal of Molecular Sciences. Vol. 22 (2021) No. 13, 6995.

[45] Liu X, Wang M, Jiang Y, et al. Magnetic resonance imaging nanoprobe quantifies nitric oxide for evaluating M1/M2 Macrophage Polarization and prognosis of cancer treatments. ACS Nano. Vol. 17 (2023) No. 24, p. 24854-24866.

[46] Gu Z, Liu T, Liu C, et al. Ferroptosis-strengthened metabolic and inflammatory regulation of tumorassociated macro-phages provokes potent tumoricidal activities. Nano Lett. Vol. 21 (2021) No. 15, p. 6471-6479.

[47] Murphy DA, Cheng H, Yang T, et al. Reversing Hypoxia with PLGA-Encapsulated Manganese Dioxide Nanoparticles Improves Natural Killer Cell Response to Tumor Spheroids. Mol Pharm. Vol. 18 (2021) No. 8, p. 2935-2946.

[48] Gao S, Li T, Guo Y, et al. Selenium-Containing Nanoparticles Combine the NK Cells Mediated Immunotherapy with Radiotherapy and Chemotherapy. Adv Mater. Vol. 32 (2020) No. 12, 1907586.

[49] Chen H, Cong X, Wu C, et al. Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9+ T cells. Sci Adv. Vol. 6 (2020) No. 5, eaax4690.

[50] Yuan S, Mu W, Liu S, et al. Transforming cancer-associated fibroblast barrier into drug depots to boost chemo-immunotherapy in “shooting fish in a barrel” pattern. ACS Nano . Vol. 17 (2023) No. 14, p. 13611-13626.

[51] Rodponthukwaji K, Thongchot S, Deureh S, et al. Development of cancer-associated fibroblasts-targeting polymeric nanoparticles loaded with 8-O-methylfusarubin for breast cancer treatment. Int J Pharm X. Vol. 8 (2024) 100294.

[52] Semkina AS, Abakumov MA, Skorikov AS, et al. Multimodal doxorubicin loaded magnetic nanoparticles for VEGF targeted theranostics of breast cancer. Nanomedicine. Vol. 14 (2018) No. 5, p. 1733-1742.

[53] Chen J, Sun X, Shao R, et al. VEGF siRNA delivered by polycation liposome-encapsulated calcium phosphate nanoparticles for tumor angiogenesis inhibition in breast cancer. Int J Nanomedicine. Vol. 12 (2017) p. 6075-6088.

[54] Yuan Z, Li Y, Zhang S, et al. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments. Mol Cancer. Vol. 22 (2023) No. 1, 48

[55] De Vita A, Liverani C, Molinaro R, et al. Lysyl oxidase engineered lipid nanovesicles for the treatment of triple negative breast cancer. Sci Rep. Vol. 11 (2021) No. 1, 5107

[56] Ikeda-Imafuku M, Gao Y, Shaha S, et al. Extracellular matrix degrading enzyme with stroma-targeting peptides enhance the penetration of liposomes into tumors. J Control Release. Vol. 352 (2022) p. 1093-1103.

[57] Carvalho JA, Abreu AS, Ferreira VTP, et al. Preparation of gelatin nanoparticles by two step desolvation method for application in photodynamic therapy. J Biomater Sci Polym Ed. Vol. 29 (2018) No. 11, p. 1287-1301.

[58] Nagarajan U, Kawakami K, Zhang S, et al. Fabrication of solid collagen nanoparticles using electrospray deposition. Chem Pharm Bull (Tokyo). Vol. 62 (2014) No. 5, p. 422-428.

[59] Muhamed I, Sproul EP, Ligler FS, et al. Fibrin Nanoparticles Coupled with Keratinocyte Growth Factor Enhance the Dermal Wound-Healing Rate. ACS Appl Mater Interfaces. Vol. 11 (2019) No. 4, p. 3771-3780.

[60] Lu B, Xiao F, Wang Z, et al. Redox-Sensitive Hyaluronic Acid Polymer Prodrug Nanoparticles for Enhancing Intracellular Drug Self-Delivery and Targeted Cancer Therapy. ACS Biomater Sci Eng. Vol. 6 (2020) No. 7, p. 4106-4115.

[61] Shi X, Yang X, Liu M, et al. Chondroitin sulfate-based nanoparticles for enhanced chemo-photodynamic therapy overcoming multidrug resistance and lung metastasis of breast cancer. Carbohydr Polym. Vol. 254 (2021) 117459.